Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Kropz shares rise as Elandsfontein mine hits record output

Mon, 20th Apr 2026 12:41

(Alliance News) - Kropz PLC shares rose on Monday after reporting a record production month and stronger quarterly output at its Elandsfontein mine in South Africa.

Shares in the Africa-focused phosphate producer and developer jumped 27% to 1.65 pence in London on Monday afternoon.

Kropz said Elandsfontein delivered a record monthly output of 40,792 tonnes of phosphate concentrate in March, surpassing the previous high of 34,070 tonnes recorded in September 2025. The company noted that four additional production records have been achieved over the past six months.

For the fourth quarter to March 31, production rose 11% to 115,686 tonnes, while sales totalled 104,900 tonnes.

The mine remains in its trial production phase.

Elsewhere, Kropz said its Hinda project has made progress following a review of alternative production scenarios. The company said optimisation work has significantly reduced water-related risks, which had previously been a challenge, improving the project's feasibility and profitability outlook.

By Eva Castanedo, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Corporate News Chemicals Construction & Materials Kropz Plc

Shares in this article

Related News

EARNINGS AND TRADING: Tekcapital swings to loss; Abingdon US update
6 hours ago

EARNINGS AND TRADING: Tekcapital swings to loss; Abingdon US update

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent
7 hours ago

IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent

ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptide...

EARNINGS AND TRADING: GenIP revenue jumps to USD520,000 in 2025
7 hours ago

EARNINGS AND TRADING: GenIP revenue jumps to USD520,000 in 2025

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

Corporate News Genip Plc + 6 more shares